Literature DB >> 21273761

The GH/IGF-I axis and pituitary function and size in adults with Prader-Willi syndrome.

I C van Nieuwpoort1, M Sinnema, J A Castelijns, J W R Twisk, L M G Curfs, M L Drent.   

Abstract

BACKGROUND: In adults with Prader-Willi syndrome (PWS), limited information is available about pituitary function, more specifically the prevalence of growth hormone deficiency (GHD). The aim of this study was to gain more insight into endocrine function in PWS adults, with emphasis on GH secretion.
METHODS: 15 randomly selected adult PWS individuals were included and 14 healthy brothers and sisters served as a control group. Main outcome measures were IGF-I, IGFBP-3 and peak GH level after a combined GHRH-arginine test. Other pituitary hormone deficits are diagnosed based on serum levels of the concerning hormones. The size of the pituitary gland was measured on MRI images.
RESULTS: In PWS adults, IGF-I levels were low and IGFBP-3 levels normal when compared to healthy controls. GHD was diagnosed in 8-38% of the PWS patients, depending on the criteria used. Hypogonadism was present in 87% of the patients. Hypothyroidism and adrenal insufficiency could also be demonstrated. Anterior pituitary size was lower in PWS individuals when compared to healthy controls.
CONCLUSION: In this study, pituitary hormone deficiencies are demonstrated in a considerable number of adults with PWS, hypogonadism and GHD being most prominent. Furthermore, the anterior pituitary is smaller in comparison with healthy controls.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273761     DOI: 10.1159/000323442

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  15 in total

1.  Growth hormone in health and disease: Prader-Willi syndrome--GH therapy and bone.

Authors:  Graziano Grugni
Journal:  Nat Rev Endocrinol       Date:  2013-04-09       Impact factor: 43.330

Review 2.  GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

Authors:  Cheri L Deal; Michèle Tony; Charlotte Höybye; David B Allen; Maïthé Tauber; Jens Sandahl Christiansen
Journal:  J Clin Endocrinol Metab       Date:  2013-03-29       Impact factor: 5.958

Review 3.  Puzzle Pieces: Neural Structure and Function in Prader-Willi Syndrome.

Authors:  Katherine E Manning; Anthony J Holland
Journal:  Diseases       Date:  2015-12-17

Review 4.  Growth Hormone Therapy in Adults with Prader-Willi Syndrome.

Authors:  Karen S Vogt; Jill E Emerick
Journal:  Diseases       Date:  2015-04-16

5.  Altered functional resting-state hypothalamic connectivity and abnormal pituitary morphology in children with Prader-Willi syndrome.

Authors:  Tonya White; Anita C Hokken-Koelega; Akvile Lukoshe; Suzanne E van Dijk; Gerbrich E van den Bosch; Aad van der Lugt
Journal:  J Neurodev Disord       Date:  2017-02-21       Impact factor: 4.025

6.  Impact of transitional care on endocrine and anthropometric parameters in Prader-Willi syndrome.

Authors:  A C Paepegaey; M Coupaye; A Jaziri; F Ménesguen; B Dubern; M Polak; J M Oppert; M Tauber; G Pinto; C Poitou
Journal:  Endocr Connect       Date:  2018-04-17       Impact factor: 3.335

Review 7.  Congenital hypothyroidism due to ectopic sublingual thyroid gland in Prader-Willi Syndrome: a case report.

Authors:  Sarah Bocchini; Danilo Fintini; Graziano Grugni; Arianna Boiani; Alessio Convertino; Antonino Crinò
Journal:  Ital J Pediatr       Date:  2017-09-22       Impact factor: 2.638

Review 8.  Prader-Willi syndrome and growth hormone deficiency.

Authors:  Zehra Aycan; Veysel Nijat Baş
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014

Review 9.  Growth hormone therapy for Prader-willi syndrome: challenges and solutions.

Authors:  Graziano Grugni; Alessandro Sartorio; Antonino Crinò
Journal:  Ther Clin Risk Manag       Date:  2016-06-02       Impact factor: 2.423

10.  Body composition, adipokines, bone mineral density and bone remodeling markers in relation to IGF-1 levels in adults with Prader-Willi syndrome.

Authors:  I Caroline van Nieuwpoort; Jos W R Twisk; Leopold M G Curfs; Paul Lips; Madeleine L Drent
Journal:  Int J Pediatr Endocrinol       Date:  2018-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.